Products for Research Use Only
RegisterLogin

Vopratelimab

CAT: 0804-HY-P99382-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99382-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Vopratelimab (JTX-2011) is a humanized immunoglobulin G1-kappa agonist monoclonal antibody that pecifically binds to the Inducible CO-Stimulator of T cells (ICOS) . Vopratelimab retains species cross-reactivity with affinities of 0.93 nM to hICOS, 0.46 nM to cynomolgus ICOS, 3.7 nM to rat ICOS, and 0.64 nM to mICOS. Vopratelimab has antitumor immune response[1].
CAS Number
2039148-04-2
Product Name Alternative
JTX 2011; 37A10
UNSPSC
12352203
Target
Others
Type
Inhibitory Antibodies
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/vopratelimab.html
Purity
99.98
Solubility
10 mM in DMSO
Smiles
[Vopratelimab]
Molecular Weight
(145.8 kDa)
References & Citations
[1]Hanson A, et, al. ICOS agonism by JTX-2011 (vopratelimab) requires initial T cell priming and Fc cross-linking for optimal T cell activation and anti-tumor immunity in preclinical models. PLoS One. 2020 Sep 24;15 (9) :e0239595.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2

Alternative Products

CatalogName
GTR18153930-01Vopratelimab
GTR18333599-01Vopratelimab Antibody
KBI1735KRIBIOLISA™ Vopratelimab ELISA
WA3801Research Grade Vopratelimab
T9901A-1610-01Vopratelimab (Mouse IgG2a)
592310Vopratelimab (ICOS, CD278)
E55B0450Vopratelimab (Reference antibody)
C00263-1mg*25Vopratelimab (Anti-ICOS / CD278)
047884ICOS/CD278 (vopratelimab) discontinued
A137709Vopratelimab Biosimilar (Monoclonal, IgG1)

Popular Products